ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 95 filers reported holding ADURO BIOTECH INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $94,000 | -31.4% | 89,000 | 0.0% | 0.00% | – |
| Q2 2019 | $137,000 | -53.1% | 89,000 | +21.4% | 0.00% | – |
| Q1 2019 | $292,000 | +50.5% | 73,300 | 0.0% | 0.00% | – |
| Q4 2018 | $194,000 | -64.0% | 73,300 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $539,000 | +5.1% | 73,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $513,000 | -4.1% | 73,300 | +27.5% | 0.00% | 0.0% |
| Q1 2018 | $535,000 | +41.9% | 57,500 | +14.3% | 0.00% | – |
| Q4 2017 | $377,000 | -29.7% | 50,300 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $536,000 | -6.5% | 50,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $573,000 | +38.4% | 50,300 | +30.6% | 0.00% | 0.0% |
| Q1 2017 | $414,000 | -5.7% | 38,500 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $439,000 | -8.4% | 38,500 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $479,000 | +10.1% | 38,500 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $435,000 | -8.8% | 38,500 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $477,000 | -46.7% | 38,500 | +21.1% | 0.00% | -50.0% |
| Q4 2015 | $895,000 | – | 31,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 3,617,653 | $5,571,000 | 0.77% |
| EcoR1 Capital, LLC | 1,761,421 | $2,713,000 | 0.27% |
| HARVARD MANAGEMENT CO INC | 640,595 | $987,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $1,540,000 | 0.06% |
| Alambic Investment Management, L.P. | 40,400 | $62,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 473,318 | $729,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 77,962 | $120,000 | 0.01% |
| Baillie Gifford | 4,070,724 | $6,269,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 348,200 | $536,000 | 0.01% |
| Assenagon Asset Management S.A. | 541,800 | $834,000 | 0.01% |